S&P 500 Futures
(0.39%) 5 259.25 points
Dow Jones Futures
(0.31%) 39 660 points
Nasdaq Futures
(0.46%) 18 298 points
Oil
(0.44%) $79.61
Gas
(0.30%) $2.31
Gold
(1.70%) $2 380.00
Silver
(2.08%) $28.96
Platinum
(1.30%) $1 003.70
USD/EUR
(-0.01%) $0.927
USD/NOK
(-0.46%) $10.82
USD/GBP
(-0.09%) $0.798
USD/RUB
(-0.21%) $92.35

实时更新: HilleVax, Inc. [HLVX]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-10)

Expected move: +/- 8.17%

BUY
50.00%
return 3.19%
SELL
0.00%
return 3.82%
最后更新时间10 May 2024 @ 04:00

3.78% $ 13.99

出售 123537 min ago

@ $14.70

发出时间: 14 Feb 2024 @ 22:30


回报率: -4.83%


上一信号: Feb 13 - 22:30


上一信号: 购买


回报率: -1.47 %

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 04:00):

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection...

Stats
今日成交量 351 148
平均成交量 141 375
市值 695.60M
EPS $-0.810 ( 2024-03-22 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.60
ATR14 $0.0320 (0.23%)
Insider Trading
Date Person Action Amount type
2024-05-01 Kohli Aditya Sell 175 Common Stock
2024-05-02 Kohli Aditya Sell 6 000 Common Stock
2024-05-03 Kohli Aditya Sell 723 Common Stock
2024-04-04 Frazier Life Sciences X, L.p. Buy 8 850 Common Stock
2024-04-03 Kohli Aditya Sell 6 000 Common Stock
INSIDER POWER
2.16
Last 79 transactions
Buy: 14 572 379 | Sell: 83 230 006

音量 相关性

長: -0.06 (neutral)
短: 0.72 (moderate)
Signal:(46.793) Neutral

HilleVax, Inc. 相关性

10 最正相关
SLDP0.881
FONR0.86
RDHL0.859
HOOK0.857
GRAY0.856
BIMI0.856
TC0.843
RBKB0.836
EQIX0.835
MARPS0.834
10 最负相关
OPNT-0.863
EWEB-0.862
EDUT-0.857
BNIXU-0.855
NTUS-0.854
DVCR-0.854
MGI-0.843
CIH-0.842
NUTX-0.839
AVEO-0.831

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

HilleVax, Inc. 相关性 - 货币/商品

The country flag 0.59
( weak )
The country flag 0.41
( neutral )
The country flag 0.58
( weak )
The country flag 0.62
( weak )
The country flag 0.69
( moderate )
The country flag -0.31
( neutral )

HilleVax, Inc. 财务报表

Annual 2023
营收: $0
毛利润: $-2.16M (0.00 %)
EPS: $-3.04
FY 2023
营收: $0
毛利润: $-2.16M (0.00 %)
EPS: $-3.04
FY 2022
营收: $0
毛利润: $-2.25M (0.00 %)
EPS: $-6.83
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-6.29

Financial Reports:

No articles found.

HilleVax, Inc.

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。